{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Formulations for non-viral in vivo transfection in the lungs", "item": "https://www.patentleaderboard.com/patent/6022737"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations for non-viral in vivo transfection in the lungs

Formulations for non-viral in vivo transfection in the lungs

US Patent 6022737 · Granted Feb 8, 2000

Estimated economic value: $389,181,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid biomarker and use thereof2025
Material and methods for treating or preventing HER-3 associated diseases2024
Protein biomarker and uses thereof2024
Nucleic acid biomarker and use thereof2023
Inhalable imatinib formulations, manufacture, and uses thereof2023
Inhalable imatinib formulations, manufacture, and uses thereof2023
Inhalable imatinib formulations, manufacture, and uses thereof2022
Inhalable imatinib formulations, manufacture, and uses thereof2022
Inhalable imatinib formulations, manufacture, and uses thereof2022
Inhalable imatinib formulations, manufacture, and uses thereof2022
K-ras mutations and anti-EGFr antibody therapy2021
K-ras mutations and anti-EGFr antibody therapy2018